Next, by examining the knockdown effect of hexokinase 2 (HK2), a key target of curcumin’s anti-glycolytic role, we sought to elucidate the importance of this enzyme as an attractive target for the development of PC therapeutics. Here, HK2 is linked to pachyonychia congenita.